331 related articles for article (PubMed ID: 2353410)
1. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
Vrzal V; Cupera Z; Chumela J; Zatloukal L
Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
[TBL] [Abstract][Full Text] [Related]
2. [Annual testing of immunity in foxes after oral rabies immunization].
Vrzal V; Matouch O
Vet Med (Praha); 1996 Apr; 41(4):107-11. PubMed ID: 8693662
[TBL] [Abstract][Full Text] [Related]
3. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of inactivated tissue culture rabies vaccine in dogs.
Strating A; Bunn TO; Goff MT; Phillips CE
J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
[TBL] [Abstract][Full Text] [Related]
5. [Vaccination of ferrets (Putorius furo) against rabies using a tissue vaccine].
Matouch O; Dousek J
Vet Med (Praha); 1986 Feb; 31(2):123-8. PubMed ID: 3083568
[TBL] [Abstract][Full Text] [Related]
6. [The effectiveness and safety of an immunization against parvovirus and rabies in anesthetized puppies].
Mayr B; Hönig A; Gutbrod F; Wiedemann C
Tierarztl Prax; 1990 Apr; 18(2):165-9. PubMed ID: 2161572
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
[TBL] [Abstract][Full Text] [Related]
9. [Serological evaluation of the efficacy of an antirabies vaccine in field dogs in Tunisia].
Haddad N
Ann Rech Vet; 1987; 18(1):63-7. PubMed ID: 3579184
[TBL] [Abstract][Full Text] [Related]
10. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.
Pimburage RMS; Gunatilake M; Wimalaratne O; Balasuriya A; Perera KADN
BMC Vet Res; 2017 May; 13(1):133. PubMed ID: 28521804
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy.
Chapat L; Hilaire F; Bouvet J; Pialot D; Philippe-Reversat C; Guiot AL; Remolue L; Lechenet J; Andreoni C; Poulet H; Day MJ; De Luca K; Cariou C; Cupillard L
Vet Immunol Immunopathol; 2017 Jul; 189():58-65. PubMed ID: 28669388
[TBL] [Abstract][Full Text] [Related]
13. Thermotolerance of an inactivated rabies vaccine for dogs.
Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
[TBL] [Abstract][Full Text] [Related]
14. [Rabies virus antibody titers in dogs in Campo Grande, Mato Grosso do Sul State, during the anti-rabies campaign, 2003].
Rigo L; Honer MR
Rev Soc Bras Med Trop; 2006; 39(6):553-5. PubMed ID: 17308701
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines.
Shiraishi R; Nishimura M; Nakashima R; Enta C; Hirayama N
J Vet Med Sci; 2014 Apr; 76(4):605-9. PubMed ID: 24389741
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of free-ranging Pennsylvania raccoons (Procyon lotor) with inactivated rabies vaccine.
Brown CL; Rupprecht CE
J Wildl Dis; 1990 Apr; 26(2):253-7. PubMed ID: 2338729
[TBL] [Abstract][Full Text] [Related]
18. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
19. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
